Adsorption of meloxicam on porous calcium silicate: Characterization and tablet formulation

被引：68

作者：

Sharma, S ^{[1
]}

Sher, P ^{[1
]}

Badve, S ^{[1
]}

Pawar, AP ^{[1
]}

机构：

[1] Bharati Vidyapeeth Deemed Univ, Dept Pharmaceut, Poona Coll Pharm, Pune 411038, Maharashtra, India

来源：

AAPS PHARMSCITECH | 2005年 / 6卷 / 04期

关键词：

Florite RE; meloxicam; adsorption; microparticles; dissolution;

D O I：

10.1208/pt060476

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The purpose of the present study was characterization of microparticles obtained by adsorption of poorly water soluble drug, meloxicam, on a porous silicate carrier Florite RE (FLR) and development of a tablet formulation using these microparticles, with improved drug dissolution properties. The study also reveals the use of FLR as a pharmaceutical excipient. Meloxicam was adsorbed on the FLR in 2 proportions (1: 1 and 1: 3), by fast evaporation of solvent from drug solution containing dispersed FLR. Drug adsorbed FLR microparticles were evaluated for surface topography, thermal analysis, X-ray diffraction properties, infrared spectrum, residual solvent, micromeritic properties, drug content, solubility, and dissolution studies. Microparticles showed bulk density in the range of 0.10 to 0.12 g/cm(3). Dissolution of drug from microparticles containing 1: 3, drug: FLR ratio was faster than microparticles containing 1: 1, drug: FLR ratio. These microparticles were used for formulating directly compressible tablets. Prepared tablets were compared with a commercial tablet. All the prepared tablets showed acceptable mechanical properties. Disintegration time of prepared tablets was in the range of 18 to 38 seconds, and drug dissolution was much faster in both acidic and basic medium from prepared tablets as compared with commercial tablet. The results suggest that FLR provides a large surface area for drug adsorption and also that a reduction in crystallinity of drug occurs. Increase in surface area and reduction in drug crystallinity result in improved drug dissolution from microparticles.

引用

页码：E618 / E625

页数：8

共 24 条

[1]

Amidon G.L., Lennernas H., Shah V.P., Crison J.R., A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm Res., 12, pp. 413-420, (1995)

[2]

Meriani F., Coceani N., Sirotti C., Voinovich D., Grassi M., In vitro nimesulide absorption from different formulations, J Pharm Sci., 93, pp. 540-552, (2004)

[3]

Perrut M., Jung J., Leboeuf F., Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes Part I. Micronization of neat particles, Int J Pharm., 288, pp. 3-10, (2005)

[4]

Kinoshita M., Baba K., Nagayasu A., Et al., Improvement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicate, J Pharm Sci., 91, pp. 362-370, (2002)

[5]

Ambike A.A., Mahadik K.R., Paradkar A., Stability study of amorphous valdecoxib, Int J Pharm., 282, pp. 151-162, (2004)

[6]

Chowdary K.P.R., Hymavathi R., Enhancement of dissolution rate of meloxicam, Ind J Pharm Sci., 63, pp. 150-154, (2001)

[7]

Smirnova I., Suttiruengwong S., Seiler M., Arlt W., Dissolution rate enhancement by adsorption of poorly soluble drugs on hydrophilic silica aerogels, Pharm Dev Technol., 9, pp. 443-452, (2004)

[8]

Streubel A., Siepmann J., Bodmeier R., Floating matrix tablet based on low density foam powder: Effects of formulation and processing parameters on drug release, Eur J Pharm Sci., 18, pp. 37-45, (2003)

[9]

Yuasa H., Takashima Y., Kanaya Y., Studies on the development of intragastric floating and sustained release preparation. I. Application of calcium silicate as a floating carrier, Chem Pharm Bull (Tokyo), 44, pp. 1361-1366, (1996)

[10]

Streubel A., Siepmann J., Bodmeier R., Floating microparticles based on low density foam powder, Int J Pharm., 241, pp. 279-292, (2002)

← 1 2 3 →